Association Between Neuroinflammation and Parkinson's Disease: A Comprehensive Mendelian Randomization Study

Area of Science:

• Neuroscience
• Genetics
• Epidemiology

Background:

• Parkinson's disease (PD) pathogenesis is complex, involving genetic and environmental factors.
• Neuroinflammation and neurotoxic mediators are implicated in neurodegenerative diseases.
• The specific role of neuroinflammatory mediators in PD etiology requires further elucidation.

Purpose of the Study:

• To investigate the causal relationship between Parkinson's disease (PD) and various neuroinflammatory and neurotoxic mediators.
• To explore potential mediating mechanisms, including the role of asthma, in the association between PD and these mediators.
• To identify specific neuroinflammatory markers causally linked to PD risk.

Main Methods:

• Two-sample Mendelian randomization (2SMR) and multivariable Mendelian randomization (MVMR) analyses were employed.
• Mediation analysis using Mendelian randomization (MR) was conducted to assess indirect effects.
• Genetic variants were used as instrumental variables to infer causality.

Main Results:

• Genetically predicted levels of nine neuroinflammatory mediators showed associations with PD risk.
• Significant associations between PD and CCL24, galectin-3, haptoglobin, and Holo-Transcobalamin-2 persisted in multivariable analyses.
• Asthma was found to mediate the effect of PD through CCL24 and galectin-3 levels.

Conclusions:

• Neuroinflammation plays a significant role in the pathogenesis of Parkinson's disease.
• Specific mediators, including CCL24 and galectin-3, are causally linked to PD.
• Asthma acts as an intermediary factor in PD development via these neuroinflammatory pathways.